Peri-Operative SGLT2/GLP-1 consideration

G. Blake Overson, D.O.

Thursday, May 14, 2026

6:45 a.m. – 7:45 a.m.
Baylor Scott and White Medical Center-Temple, TX

Medical Education Center,  Room 110 & 111- Microsoft Teams

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Review pharmacology and physiology of SGLT2 and GLP 1 medications

2. Discuss Anesthetic considerations on patients taking SGLT2 and GLP1 medications.

3 .Describe treatment and follow-up care for patients experiencing complications related to SGLT2 and GLP1 medications in

the perioperative period.

FACULTY DISCLOSURE: Dr. G. Blake Overson has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Amy Sanders. [email protected]